Search research articles
Contact Us
Filters
Showing results (1-10 of 237) with videos related to
Page
of 24
Sort By:
Current Drug Metabolism
|
March 29, 2012
Drug metabolism in pediatrics, pregnancy and lactation
Saskia N de Wildt
Expert Opinion on Drug Metabolism & Toxicology
|
May 10, 2011
Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children
Saskia N de Wildt
The Lancet. Child & Adolescent Health
|
April 13, 2026
Model-informed precision dosing: from a niche for pharmacologists to daily business of paediatricians?
Saskia N de Wildt
Journal of Clinical Epidemiology
|
July 13, 2015
Drug trials: Kids are no little adults and not all kids are the same
Rianne Oostenbrink, Saskia N de Wildt
Nederlands Tijdschrift Voor Geneeskunde
|
May 28, 2015
[Ethical aspects of clinical drug research in critically ill children]
Krista Tromp, Saskia N de Wildt
Paediatric Anaesthesia
|
October 26, 2011
Prevention of Low Cardiac Output Syndrome in children: where is the evidence?
Annewil Van Saet, Saskia N De Wildt
British Journal of Clinical Pharmacology
|
May 2, 2022
Innovative methodologies in paediatric drug development: A conect4children (c4c) special issue
Saskia N de Wildt, Ian C K Wong
Drug Discovery Today
|
August 30, 2008
Challenges for drug studies in children: CYP3A phenotyping as example
Saskia N de Wildt, Shinya Ito, Gideon Koren
Paediatric Anaesthesia
|
December 5, 2018
Reply to Stamer, Ulrike; Stüber, Frank, regarding their comment 'Analgesic efficacy of dipyrone children - Still an absence of evidence'
Thomas G de Leeuw, Saskia N de Wildt
European Journal of Clinical Pharmacology
|
April 28, 2009
Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children
Saskia N de Wildt, Catherijne A J Knibbe
Page
of 24
Search research articles
Search
Showing results (1-10 of 237) with videos related to
Sort By:
Page
of 24
Current Drug Metabolism
|
March 29, 2012
Drug metabolism in pediatrics, pregnancy and lactation
Saskia N de Wildt
Expert Opinion on Drug Metabolism & Toxicology
|
May 10, 2011
Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children
Saskia N de Wildt
The Lancet. Child & Adolescent Health
|
April 13, 2026
Model-informed precision dosing: from a niche for pharmacologists to daily business of paediatricians?
Saskia N de Wildt
Journal of Clinical Epidemiology
|
July 13, 2015
Drug trials: Kids are no little adults and not all kids are the same
Rianne Oostenbrink, Saskia N de Wildt
Nederlands Tijdschrift Voor Geneeskunde
|
May 28, 2015
[Ethical aspects of clinical drug research in critically ill children]
Krista Tromp, Saskia N de Wildt
Paediatric Anaesthesia
|
October 26, 2011
Prevention of Low Cardiac Output Syndrome in children: where is the evidence?
Annewil Van Saet, Saskia N De Wildt
British Journal of Clinical Pharmacology
|
May 2, 2022
Innovative methodologies in paediatric drug development: A conect4children (c4c) special issue
Saskia N de Wildt, Ian C K Wong
Drug Discovery Today
|
August 30, 2008
Challenges for drug studies in children: CYP3A phenotyping as example
Saskia N de Wildt, Shinya Ito, Gideon Koren
Paediatric Anaesthesia
|
December 5, 2018
Reply to Stamer, Ulrike; Stüber, Frank, regarding their comment 'Analgesic efficacy of dipyrone children - Still an absence of evidence'
Thomas G de Leeuw, Saskia N de Wildt
European Journal of Clinical Pharmacology
|
April 28, 2009
Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children
Saskia N de Wildt, Catherijne A J Knibbe
Page
of 24